GALLIXA

Welcome to the Brand page for “GALLIXA”, which is offered here for Anti-diabetic pharmaceuticals; antibacterial pharmaceuticals; antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, and pharmaceuticals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; ocular pharmaceuticals; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations namely,appetite suppressants; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceuticals, anti-infectives; pharmaceuticals, antihelmintics for human use; pharmaceuticals, lipid lowering agents; all of the foregoing shall be exclusively for human use;.

Its status is currently believed to be active. Its class is unavailable. “GALLIXA” is believed to be currently owned by “Bernstein, Lawrence R.”